Vaccinome Landscape in Nearly 620 000 Patients With Diabetes - Poll - MDSpire

Vaccinome Landscape in Nearly 620 000 Patients With Diabetes

  • By

  • Francesca D’Addio

  • Elisa Lazzaroni

  • Maria Elena Lunati

  • Giuseppe Preziosi

  • Michele Ercolanoni

  • Giulio Turola

  • Chiara Marrocu

  • Giovanni Cicconi

  • Sudwaric Sharma

  • Simona Scarioni

  • Laura Montefusco

  • Ida Pastore

  • Paola Silvia Morpurgo

  • Antonio Rossi

  • Alessandra Gandolfi

  • Camilla Tinari

  • Giada Rossi

  • Moufida Ben Nasr

  • Cristian Loretelli

  • Roberta Maria Fiorina

  • Baldassarre Grassa

  • Rosa Terranova

  • Loredana Bucciarelli

  • Cesare Berra

  • Danilo Cereda

  • Gianvincenzo Zuccotti

  • Catia Rosanna Borriello

  • Paolo Fiorina

  • July 23, 2024

  • 0 min

Share

Original Source(s)

Vaccinome Landscape in Nearly 620 000 Patients With Diabetes

  • by Francesca D’Addio, Elisa Lazzaroni, Maria Elena Lunati, Giuseppe Preziosi, Michele Ercolanoni, Giulio Turola, Chiara Marrocu, Giovanni Cicconi, Sudwaric Sharma, Simona Scarioni, Laura Montefusco, Ida Pastore, Paola Silvia Morpurgo, Antonio Rossi, Alessandra Gandolfi, Camilla Tinari, Giada Rossi, Moufida Ben Nasr, Cristian Loretelli, Roberta Maria Fiorina, Baldassarre Grassa, Rosa Terranova, Loredana Bucciarelli, Cesare Berra, Danilo Cereda, Gianvincenzo Zuccotti, Catia Rosanna Borriello, Paolo Fiorina

  • July 23, 2024

Related Content

Assessment of Two-Phase Diagnostic Timelines in Diabetic Retinopathy and Contributing Factors: A Cross-Sectional Analysis

Influenza Vaccine Dose and Dementia Outcomes

US claims data compare high- vs standard-dose formulations in patients aged 65 years or more over 3 years of follow-up

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort